ORTHOPEDIC BIOMATERIAL MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Orthopedic Biomaterial Market Analysis & Forecast- 2026-2033

Orthopedic Biomaterial Market is estimated to be valued at USD 20.87 Bn in 2026 and is expected to reach USD 40.94 Bn in 2033, exhibiting a compound annual growth rate (CAGR) of 10.1% from 2026 to 2033.

Key Takeaways

• According to Material Type, The Glass-Ceramic & Bioactive Glasses Category is anticipated to account for the largest share of 42.2% for the Orthopedic Biomaterial market in 2026. High mechanical strength and wear resistance are provided by glass-ceramics and bioactive glasses, which are essential for load-bearing orthopedic applications.
• According to region, North America holds the largest market share of 44.60% for Orthopedic Biomaterial market growth by 2026. Market expansion is being accelerated by regulatory approvals for new devices such as FDA’s historic designation for innovative ceramic knee replacements.

Market Overview

The Orthopedic Biomaterial Market Size is experiencing robust growth due to advancements in biomaterial technologies and also product innovations. The market for orthopedic biomaterials is expanding rapidly due to factors such as the growing need for orthopedic implants, the prevalence of musculoskeletal conditions, and the rise in trauma and sports-related injuries.

For instance, in September 2024, Temple OrthoBiologics, a new venture spun out from women’s health company Temple Therapeutics, is proud to announce its official launch heralding a breakthrough in orthopedic sports medicine. For years, the prevention of scar tissue was considered impossible. Temple OrthoBiologics is changing that narrative.

Current Events and Its Impact on the Orthopedic Biomaterial Market

Segmental Insights

Orthopedic Biomaterial Market Insights, By Material Type

Based on material type, the glass-ceramic & bioactive glasses contribute the 42.2% share of the market owing to its superior properties and advantages over other biomaterials. Their superior mechanical strength and controlled degradation make them ideal for implants and bone regeneration, offering distinct advantages over polymers and metals in clinical applications.

Orthopedic Biomaterial Market Insights, By Application

Based on application, the joint replacement contributes the highest share of the market, this is attributed to the rising cases of osteoarthritis and musculoskeletal disorders globally. Aging populations and sedentary lifestyles contribute to joint degeneration, driving demand for advanced biomaterials that enhance implant durability, biocompatibility, and patient outcomes in hip, knee, and shoulder replacements.

Orthopedic Biomaterial Market Insights, By End User

Based on end user, the hospitals contribute the highest share of the market, owing to the high volume of orthopedic procedures like joint replacement, spinal fusion, and orthopedic biomaterial for Bone Fixation performed at inpatient facilities. Their advanced infrastructure, skilled personnel, and access to cutting-edge biomaterials make them the primary setting for complex orthopedic interventions, driving their leading market share

Regional Insights

North America Orthopedic Biomaterial Market

North America is estimated to hold a dominant position in the global orthopedic biomaterial market over the forecast period. North America is estimated to hold 44.60% of the market share in 2026. The North America region is expected to dominate the global orthopedic biomaterial market over the forecast period.

The presence of major medical device manufacturers in the U.S. is a key factor driving growth in this region. The U.S. is home to large multinational corporations like Johnson & Johnson, Stryker, Zimmer Biomet, and Medtronic, all medical technology companies which together account for over 80% of the orthopedic biomaterial market in the region.

Moreover, increasing acquisitions between market players are expected to drive the market growth in the region. For instance, in September 2023, Restor3d, the U.S.-based manufacturer of 3D-printed orthopedic implants, announced the completion of its previously announced acquisition of restor3d, a company that manufactures customized knee and hip replacements. Restor3d provides patient-specific, patient-matched, and auxiliary goods. Its specialty is in 3D printing osseointegrative biomedical materials.

Europe Orthopedic Biomaterial Market

Europe region is anticipated to be the fastest growing region in the orthopedic biomaterials market. The region’s growth is underpinned by a robust healthcare infrastructure, a high volume of orthopedic surgeries, and strong emphasis on research and development leading to innovative treatment options. European countries benefit from widespread adoption of advanced biomaterials for joint replacements, fracture fixation, and other orthopedic applications.    

Orthopedic Biomaterial Market Dominating Countries

U.S Orthopedic Biomaterial Market

The U.S. benefits from advanced healthcare infrastructure, strong reimbursement frameworks, and significant investments in research and development, which drive the adoption of innovative biomaterial products. The presence of major industry players and a focus on minimally invasive procedures further support the country’s leadership in this sector.   

India Orthopedic Biomaterial Market

Due to its huge and increasingly aging population, increased incidence of bone degenerative disorders, and rising healthcare costs, India is becoming one of the Asia Pacific region's fastest-growing markets for orthopedic biomaterials.  Due to an increase in joint replacement surgeries and the rising number of trauma and sports injuries, the nation is seeing a strong demand for orthopedic implants and biomaterials.    

China Orthopedic Biomaterial Market

China is a major contributor to the growth of the worldwide orthopedic biomaterials market because of its large population, fast urbanization, and increasing musculoskeletal disease prevalence.  The country is experiencing increased demand for orthopedic implants and biomaterials, supported by expanding healthcare infrastructure and government policies aimed at modernizing medical services.

Market Report Scope

Orthopedic Biomaterial Market Trends

• Increasing Mergers and Acquisitions 

Mergers and acquisitions are reshaping the Orthopedic Biomaterial Market, driving innovation and expanding market share. In 2025, leading companies like Zimmer Biomet, Heraeus Medical, and Keensight Capital executed strategic acquisitions to enhance their biomaterial portfolios and technological capabilities. These deals aim to integrate advanced regenerative solutions and robotic technologies, fueling growth and competitiveness. As consolidation intensifies, it strengthens global distribution networks and accelerates product development, ultimately influencing the Orthopedic Biomaterial Market share across joint reconstruction, orthobiologics, and spinal applications.

Orthopedic Biomaterial Market Opportunities

Additionally, innovations such as 3D printing, nanotechnology, and biofabrication are enabling the development of personalized orthopedic implants tailored to individual patient anatomy and needs. These technologies facilitate the creation of complex, bone-mimicking structures with superior mechanical properties and bioactivity, improving both integration and long-term outcomes for patients.

Nanotechnology, in particular, is being leveraged to produce implants with enhanced surface features that mimic natural bone, promote better cell attachment, and reduce infection risk, addressing some of the limitations of traditional materials. 

Orthopedic Biomaterial Market Growth Drivers

• Rising Prevalence of Musculoskeletal Disorders 

The rising prevalence of musculoskeletal disorders such as osteoarthritis, rheumatoid arthritis, and osteoporosis is a major driver propelling the growth of the global orthopedic biomaterial market. For instance, according to the Centers for Disease Control and Prevention (CDC), June 2023, 1 in 4 (or 53.2 million) U.S. adults had some form of arthritis in 2021. While there are estimated to be more than 100 types of arthritis, osteoarthritis (OA) is the most common form of arthritis, affecting 32.5 million U.S. adults.

The aging population and obesity epidemic have significantly contributed to the increasing musculoskeletal disease burden. With life expectancy rising globally, the World Health Organization (WHO) report for 2022 estimates that the population aged 60 years or older will increase from 1 billion in 2020 to 1.4 billion by 2030.

Since advanced age is a prominent risk factor for osteoarthritis, osteoporosis, and other musculoskeletal conditions, the exponential growth of the elderly demographic will lead to a higher disease burden and greater demand for orthopedic treatments involving biomaterials.

• Advancements in Orthopedic Biomaterials and Implant Technology 

Continual advances in orthopedic biomaterials and implant designs are driving market expansion by improving clinical outcomes and the longevity of implants. Active research is underway to develop innovative biomaterials like porous titanium, biodegradable polymers, and 3D printed constructs that can better integrate with native bone, stimulate bone regeneration, and reduce stress shielding compared to traditional metal implants.

For instance, in July 2023, Himed, a biomaterials company located in the U.S., and Lithoz, a worldwide industry leader in 3D printing based in Austria, announced a collaboration to create novel bioceramic feedstocks. The two companies have entered into a long-term strategic materials research partnership agreement to investigate novel integrations of Himed's calcium phosphate (CaP) biomaterials with Lithoz's proprietary ceramic binder utilized in their cutting-edge CeraFab S65 medical 3D printer.

Orthopedic Biomaterial Market: Key Developments

• In February 2025, Evergen, unveiled new AI-powered image processing software to advance the analysis of CT bone graft scans. In order to determine how best to use the graft and, ultimately, which patients would benefit the most, bone graft scans are used to evaluate bone density and structure.
• In March 2025, Demetra Holding, announced its acquisition of a 51% stake in GetSet Surgical, a leading Swiss-based spine surgical solutions provider.
• In June 2024, Zhengzhou Vtops Machinery Co., Ltd. (VTOPS) is proud to announce the launch of its latest upgraded 2.5kg milk powder filling and can sealing machines. These two pieces of equipment are specifically designed for filling 2.5kg milk powder into cans with a diameter of 189mm, bringing significant improvements in production efficiency and product quality assurance to milk powder manufacturers.

Analyst Opinion ( Expert Opinion)

• The orthopedic biomaterial market is expected to see steady growth in the coming years, driven by an aging population and a rise in musculoskeletal disorders. There is increasing demand for effective biomaterial implants that can improve patient outcomes and quality of life.
• Polymeric biomaterials such as PEEK and ultra-high molecular weight polyethylene dominate the market due to favorable properties like biocompatibility, durability, and imaging compatibility.
• However, concerns around wear debris and subsequent osteolysis remain a restraint for traditional polymer implants. This provides opportunities for new biomaterial technologies like biodegradable magnesium metal and porous titanium implants. These can potentially address unmet needs by promoting bone growth and minimizing stress-shielding effects

Market Segmentation

• Global Orthopedic Biomaterial Market, By Material Type (Revenue, USD Bn, 2021 - 2033)
• Glass-ceramic & Bioactive Glasses
• Calcium Phosphate Cements
• Polymer
• Metals
• Composites
• Global Orthopedic Biomaterial Market, By Application (Revenue, USD Bn, 2021 - 2033)
• Joint Replacement
• Spine Implants
• Orthobiologics
• Viscosupplementation
• Bio-resorbable Tissue Fixation
• Global Orthopedic Biomaterial Market, By End user (Revenue, USD Bn, 2021 - 2033)
• Hospitals
• Orthopedic Clinics
• Other
• Global Orthopedic Biomaterial Market, By Region (Revenue, USD Bn, 2021 - 2033)
• North America
• U.S.
• Canada
• Latin America
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Europe
• Germany
• U.K.
• France
• Italy
• Spain
• Russia
• Rest of Europe
• Asia Pacific
• India
• Japan
• Australia
• South Korea
• ASEAN
• Rest of Asia Pacific
• Middle East
• GCC
• Israel
• Rest of Middle East
• Africa
• South Africa
• Central Africa
• North Africa
• Company Profiles
• B.Braun Melsungen AG
• CONMED Corporation
• Evonik Industries AG
• Medtronic Plc.
• Smith & Nephew Plc.
• Stryker Corp
• Victrex Plc.
• Zimmer Biomet Holdings Inc.
• Globus Medical
• Heraeus Holding GmbH
• Exactech Inc.
• Collagen Matrix Inc.
• Koninklijke DSM N.V. (DSM Biomedical B.V.),
• Invibio Ltd.
• DePuy Synthes

Sources

Primary Research Interviews

• Orthopedic Surgeons
• Biomedical Engineers
• Hospital Procurement Managers
• Medical Device Manufacturers
• Regulatory Affairs Specialists

Databases

• ScienceDirect
• Scopus
• Embase
• ClinicalTrials.gov
• SpringerLink
• IEEE Xplore

Magazines

• Medical Device and Diagnostic Industry (MD+DI)
• Orthopedic Design & Technology
• MedTech Insight
• MedCity News

Journals

• Journal of Biomedical Materials Research
• Biomaterials
• Journal of Orthopaedic Research
• Clinical Orthopaedics and Related Research
• Acta Biomaterialia

Newspapers

• The Wall Street Journal – Health Section
• The New York Times – Health Section
• The Economic Times – Healthcare
• The Hindu Business Line – Life Sciences

Associations

• American Academy of Orthopaedic Surgeons (AAOS)
• Orthopaedic Research Society (ORS)
• Society for Biomaterials (SFB)
• International Society for Orthopaedic Surgery and Traumatology (SICOT)
• ASTM International – Committee F04 (Medical and Surgical Materials and Devices)

Proprietary Elements

• CMI Data Analytics Tool
• Proprietary CMI Existing Repository of information for last 8 years